HN

Hemang Nileshkumar Raval

Active Director Director DIN 08298157
DIN 08298157 First appointment Dec 2018 Primary industry Food And Beverages
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Hemang Nileshkumar Raval

Data last updated:

Hemang Nileshkumar Raval is a Director at Curecorp Pharmaceuticals And Healthtech Private Limited (since 2018). The company operates in Food And Beverages.

DIN 08298157
Primary Designation Director
Industry Food And Beverages
First Appointment 07 Dec 2018
Oldest Company Age 7 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 Dec 20182018Active

Board colleagues of Hemang Nileshkumar Raval

Directorship timeline

Open interactive timeline →
Curecorp Pharmaceuticals And Healthtech Private Limited
Premium access

Shareholding and investment profile for Hemang Nileshkumar Raval

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hemang Nileshkumar Raval

Hemang Nileshkumar Raval currently holds 1 directorship: Curecorp Pharmaceuticals And Healthtech Private Limited (Director, since 07 Dec 2018).

Hemang Nileshkumar Raval was first appointed on 07 Dec 2018 as Director at Curecorp Pharmaceuticals And Healthtech Private Limited.

The current boards of Hemang Nileshkumar Raval's companies include Sangeeta Nileshkumar Raval (Curecorp Pharmaceuticals And Healthtech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available